GlassScriptPhysician profile
Neil J Wimmer
NPI 1821153065
$3,646.92
in general payments reported to CMS, 2019-2025
19 companies · $992 in 2025
The $992 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $413 · 2021: $217 · 2022: $231 · 2023: $1,000 · 2024: $425 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,169 · Travel and Lodging: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,169.43 |
| Travel and Lodging | $247.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,112.53 | 2019-2025 | Evoque, Pascal |
| Medtronic, INC. | $625.74 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abiomed | $623.18 | 2019-2025 | Impella |
| Boston Scientific Corporation | $287.12 | 2020-2024 | |
| Abbott Laboratories | $247.53 | 2023-2025 | Amplatzer Amulet, Triclip, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $147.19 | 2019-2024 | Brilinta |
| Medtronic Vascular, INC. | $147.08 | 2020 | |
| Kestra Medical Technology Services, INC. | $74.02 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $66.18 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.06 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $49.20 | 2019 | |
| Shockwave Medical, INC | $47.39 | 2025 | |
| Janssen Pharmaceuticals, INC | $44.71 | 2019 | |
| Pfizer INC. | $34.49 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $30.32 | 2019-2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $24.06 | 2023 | Ffrct |
| Amgen INC. | $15.97 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.15 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Wimmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.